- Home
- KROS vs AVDX Comparison
KROS vs AVDX Comparison
Compare KROS & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- AVDX
- Stock Information
- Founded
- KROS 2015
- AVDX 2000
- Country
- KROS United States
- AVDX United States
- Employees
- KROS N/A
- AVDX N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- AVDX EDP Services
- Sector
- KROS Health Care
- AVDX Technology
- Exchange
- KROS Nasdaq
- AVDX Nasdaq
- Market Cap
- KROS 558.9M
- AVDX 2.0B
- IPO Year
- KROS 2020
- AVDX 2021
- Fundamental
- Price
- KROS $13.45
- AVDX $9.85
- Analyst Decision
- KROS Buy
- AVDX Hold
- Analyst Count
- KROS 13
- AVDX 15
- Target Price
- KROS $20.63
- AVDX $10.04
- AVG Volume (30 Days)
- KROS 603.2K
- AVDX 2.7M
- Earning Date
- KROS 08-06-2025
- AVDX 07-30-2025
- Dividend Yield
- KROS N/A
- AVDX N/A
- EPS Growth
- KROS N/A
- AVDX N/A
- EPS
- KROS 0.11
- AVDX 0.01
- Revenue
- KROS $214,713,000.00
- AVDX $441,284,000.00
- Revenue This Year
- KROS $5,006.76
- AVDX $5.56
- Revenue Next Year
- KROS N/A
- AVDX $10.01
- P/E Ratio
- KROS $123.44
- AVDX $1,103.36
- Revenue Growth
- KROS 91657.70
- AVDX 10.46
- 52 Week Low
- KROS $9.12
- AVDX $6.61
- 52 Week High
- KROS $72.37
- AVDX $12.93
- Technical
- Relative Strength Index (RSI)
- KROS 43.42
- AVDX 71.38
- Support Level
- KROS $13.24
- AVDX $9.79
- Resistance Level
- KROS $13.77
- AVDX $9.81
- Average True Range (ATR)
- KROS 0.38
- AVDX 0.03
- MACD
- KROS -0.04
- AVDX -0.03
- Stochastic Oscillator
- KROS 28.00
- AVDX 94.44
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.